PR NEWSWIRE

Previous Stories

BLUETTI Australia Launches Christmas Sale

Dec 24 2021 - PR NewsWire

SYDNEY, Dec. 24, 2021 /PRNewswire/ — BLUETTI now offers Christmas deals online. To celebrate the Christmas season and help customers…


Vestas together with Deutsche Bank, Sinosure and Global Power Generation replicate the fourth payment deferral facility during 2021 to finance the 58MW Crookwel

Dec 23 2021 - PR NewsWire

MELBOURNE, Australia, Dec. 23, 2021 /PRNewswire/ — In partnership with Global Power Generation (GPG), Deutsche Bank AG and Sinosure, Vestas has…


SOR Automation & Robotics Technology Success

Dec 23 2021 - PR NewsWire

PERTH, Australia, Dec. 23, 2021 /PRNewswire/ — Strategic Elements Ltd (ASX: SOR) is pleased to report that the 100% owned…


FP Markets Expands Offering by adding New Products

Dec 22 2021 - PR NewsWire

New products via FP Markets Metatrader 4 (MT4) & Metatrader 5 (MT5) Platform include Bonds, Commodities, Cryptocurrency CFDs and Equities….


Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

Dec 22 2021 - PR NewsWire

US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology. LEAP™ enables large-scale,…


Australia’s first laser nuclear fusion company appoints world-leading scientific board; publishes groundbreaking research

Dec 22 2021 - PR NewsWire

SYDNEY, Dec. 22, 2021 /PRNewswire/ — Australia’s first laser nuclear fusion energy company HB11 Energy has formally appointed a scientific…


Landis+Gyr Divests Stake in Intellihub Joint Venture

Dec 22 2021 - PR NewsWire

CHAM, Switzerland and SYDNEY, Dec. 22, 2021 /PRNewswire/ — Landis+Gyr Group AG (SIX: LAND), a leading provider of integrated energy…


First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Dec 20 2021 - PR NewsWire

Study to evaluate ATG-101, a proprietary PD-L1/4-1BB bispecific antibody Study will enroll patients with Metastatic/Advanced Solid Tumors and Mature B-Cell…


First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Dec 20 2021 - PR NewsWire

Study to evaluate ATG-101, a proprietary PD-L1/4-1BB bispecific antibody Study will enroll patients with Metastatic/Advanced Solid Tumors and Mature B-Cell…


Moomoo to launch in Australia: will offer Australian Investors One-Stop Online Investment Services

Dec 20 2021 - PR NewsWire

SYDNEY, Dec. 20 2021 /PRNewswire/ — On December 20, 2021 (Australia time), moomoo, a leading one-stop digital investment platform, announced that…


Analyse The Market From A Different Angle